RNA Therapeutics: siRNA, mRNA, and LNP Delivery IP The RNA therapeutics space, covering small interfering RNA (siRNA), antisense oligonucleotides (ASOs), and mRNA therapeutics, has a multi-layered patent landscape across three domains: the nucleic acid sequence itself, the chemical modifications that improve stability and reduce immunogenicity, and the delivery vehicle
For many patients, the price has been steep, sometimes exceeding $1,000 per month without insurance coverage
This demonstrates that GLP-1R function is critical for normal brain metabolic function
Besides inducing considerable weight loss, their impact on the digestive system and metabolism may cause some adverse reactions
On April 30, 2026, the FDA proposed formally excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulks List - which would eliminate the remaining legal pathway for 503B outsourcing facilities to compound these medications in bulk
Contact Us We speak English, Spanish, Russian